Long Grove Pharmaceuticals is an experienced and innovative pharmaceutical company focused on complex generics and proprietary 505(b)(2)s. Long Grove has a heritage of proven success with in-house research and development from our parent company, Capstone Development Services.

Long Grove approaches the generic pharmaceutical market with innovative People, Products and Processes. Our innovative approach includes:

• In-House R&D - We develop differentiated generics designed to ease operational burdens in healthcare, supported by our parent company, Capstone Development Services

• Dedicated Supply Chains - We unleash new and incremental supply to the U.S. market through our partnerships with well-established global manufacturers, primarily in Europe and North America.

• Experience in Leadership - Long Grove’s seasoned leadership team brings decades of industry experience. The team prides itself on establishing collaborative and transparent partnerships with customers and suppliers.

We deliver truly differentiated generics to market by focusing on the following:

• Proprietary products developed in-house through the 505(b)(2) regulatory pathway help us deliver novel solutions to our customers.

• Rapid product approvals and process efficiencies supported by our entrepreneurial and agile parent organization.

• Supply chain continuity reinforced by investing in capacity, equipment and strategic inventory.

• Collaborative and reliable partnerships with our manufacturers, developers, suppliers and customers.